{
"NDC": {
"NDCCode": "70709-152-50",
"PackageDescription": "60 TABLET in 1 BOTTLE (70709-152-50) ",
"NDC11Code": "70709-0152-50",
"ProductNDC": "70709-152",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Phyrago",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Dasatinib",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20250922",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA216099",
"LabelerName": "Cycle Pharmaceuticals Ltd",
"SubstanceName": "DASATINIB",
"StrengthNumber": "50",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-09-23",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250922",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}